Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEvome Medical Technologies Inc.

Evome Medical Technologies Inc.

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2026-11-04T21:00:05.301058Z
Market Cap
0.41M

Momentum Score

…

Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Evome Medical Technologies Inc., listed on the TSX Venture Exchange (EVMT.V), is limited; the company operates in the medical technologies sector. As an early-stage device developer, long-term growth drivers could include successful product development, regulatory approvals and commercial adoption in target clinical markets, which may benefit from aging populations and rising healthcare spending.

Key investment risks are early-stage execution and clinical/regulatory uncertainty, need for additional financing, thin public-market liquidity and competing technologies; investors should monitor regulatory milestones, funding resources and commercialization progress.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
48.34M
Revenue Per Share
0.55
Gross Profit TTM
16.34M
Debt / Equity
-
ROE
-294.80%
Net Debt
15.86M
ROCE
-57.38%
Diluted EPS TTM
-0.29

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-11-30 2021-11-30 2020-11-30 2019-11-30
Type yearly yearly yearly yearly
Date 2023-11-30 2021-11-30 2020-11-30 2019-11-30
Income before tax -15.55M -4.47M -4.47M -1.35M
Net income -15.60M -4.37M -4.37M -1.92M
Selling general administrative 24.16M 5.73M 9.57M 1.65M
Gross profit 22.53M 5.96M 5.96M 0.33M
Reconciled depreciation 2.48M 0.84M 0.84M 0.05M
Operating income -6.13M -0.61M -4.45M -1.31M
Interest expense 2.64M 0.39M 0.39M -
Tax provision 0.06M -0.10M -0.10M 0.00M
Net interest income -2.64M -0.39M -0.39M -
Total revenue 62.63M 18.31M 18.31M 0.35M
Total operating expenses 68.76M 18.92M 22.76M 1.66M
Cost of revenue 40.09M 12.35M 12.35M 0.02M
Total other income expense net -6.77M -3.48M 0.37M -0.04M
Net income from continuing ops -15.60M -4.37M -4.37M -1.35M
Breakdown 2023-11-30 2021-11-30 2020-11-30 2019-11-30
Type yearly yearly yearly yearly
Date 2023-11-30 2021-11-30 2020-11-30 2019-11-30
Total assets 48.26M 42.68M 13.13M 9.73M
Intangible assets 7.03M 6.93M - -
Total liab 44.25M 29.53M 6.49M 0.23M
Total stockholder equity 4.00M 13.15M 6.64M 9.50M
Other current liab 10.90M 13.56M 5.44M 0.01M
Capital stock 53.51M 38.53M 31.07M 31.06M
Retained earnings -64.86M -33.36M -28.99M -26.33M
Good will 6.40M 9.83M 0.00M -
Cash 0.92M 8.06M 7.08M 8.35M
Total current liabilities 37.57M 23.16M 6.49M 0.23M
Net debt 15.86M - - -
Short long term debt 16.52M 5.67M - -
Total current assets 21.00M 20.04M 13.13M 9.73M
Short term investments - 0.00M 0.49M 0.84M
Net receivables 7.80M 6.36M 0.00M 0.00M
Long term debt 0.26M 0.68M - -
Inventory 10.24M 4.97M 0.00M -
Accounts payable 6.91M 2.86M 0.48M 0.17M
Non current assets total 27.25M 22.65M 0.00M 0.00M
Capital lease obligations 7.91M 4.18M 0.00M -
Breakdown 2023-11-30 2022-11-30 2021-11-30 2020-11-30 2019-11-30
Type yearly yearly yearly yearly yearly
Date 2023-11-30 2022-11-30 2021-11-30 2020-11-30 2019-11-30
Investments -1.52M - -4.62M -4.62M -0.90M
Total cash from financing activities 0.82M - 3.94M 3.94M 0.00M
Net income -15.60M -19.08M -4.37M -2.67M -1.92M
Change in cash -1.61M - -4.39M -4.39M -1.10M
Begin period cash flow 1.93M 8.06M 12.51M 12.51M 9.30M
End period cash flow 0.92M 1.93M 8.06M 8.06M 8.35M
Total cash from operating activities -0.92M - -3.70M -3.70M -0.20M
Issuance of capital stock - - 4.26M 4.26M -
Depreciation 2.48M - 0.84M 0.84M 0.05M
Change to inventory 4.65M - 0.25M 0.25M -
Change to account receivables -1.90M - -2.07M -2.07M -
Capital expenditures 0.20M 0.00M 0.06M 0.06M 0.00M
Change in working capital -0.92M - -0.21M -0.21M 0.75M
Stock based compensation 1.29M - 1.20M 1.20M 0.02M
Other non cash items -2.39M - -5.65M -5.65M -
Free cash flow -1.12M - -3.76M -3.76M -0.20M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TLT
Theralase Technologies Inc.		 0.01
2.78%		 0.18 - - 90.07 82.51 90.31 -12.06
CNVI
Conavi Medical Corp.		 -0.01
4.55%		 0.10 - - 66.65 - 95.30 -
PINK
Perimeter Medical Imaging AI Inc		 -
-%		 0.18 4.13 - 18.78 11.34 20.22 -2.55
CHER
Cheelcare Inc.		 -
-%		 1.25 - - 20.92 106.42 21.26 -

Profile*

Evome Medical Technologies Inc.

Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.

49 Natcon Drive, Shirley, NY, United States, 11967

800 760 6826

https://www.evomemedical.com

195

Name Title Year Born
Mr. Michael Seckler CEO & Executive Director 1966
Ms. Cherine Pottinger-Harris Principal Accounting Officer & Interim Chief Financial Officer 1981
Mr. William Hauer Vice President of Marketing & Sales NA
Ms. Heydi Benson Director of Human Resources NA
Mr. Jethro Rothe-Kushel Vice President of Capital Markets & Financial Communications NA
Jeffrey Chu Executive Officer NA
Mr. Christopher Heath Interim CEO & Director NA
Mr. William N. Garbarini Jr. Chief Operating Officer 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…